BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

New Biopharmaceutical Company, Caliber Biotherapeutics to Accelerate Delivery of Vaccines and Protein Therapeutics


4/25/2011 10:58:01 AM

BRYAN/COLLEGE STATION, Texas, April 25, 2011 /PRNewswire/ -- Caliber Biotherapeutics, a fully-integrated biopharmaceutical company, announced the opening of the world's largest plant-made pharmaceutical manufacturing facility in Bryan, Texas, with the capability of producing 10-100 million doses of infectious vaccines per month, and hundreds of thousands of doses of protein biotherapeutics such as monoclonal antibodies.

In addition to its plant-based facility, Caliber will also develop a proprietary product pipeline for cancer and infectious diseases utilizing cell- and microbial-based production systems. The end result will be new, more effective and affordable vaccines and biotherapeutics for patients delivered in a time frame in which they are needed.

Led by physician-scientist and biodefense expert, Brett Giroir, M.D., and Barry Holtz, Ph.D., an internationally recognized pioneer in plant-made pharmaceuticals, Caliber Biotherapeutics represents a fundamentally different approach to vaccine and drug development.

"With plant-based systems, we have an unprecedented level of flexibility and scalability," said Dr. Holtz, Caliber's Chief Scientific Officer. "This enables simultaneous production of multiple proteins and rapid change-overs from one product to another in order to meet patients' needs and respond to emerging infectious diseases and bioterror threats."

"The Caliber platform is designed to be uniquely agile and responsive, enabling us to accelerate development of products with improved efficacy, reduced cost and enhanced safety," said Dr. Giroir, Chief Medical Officer. "Our goal is to make a rapid, meaningful impact on patients with unmet medical needs, both in the United States as well as in lesser developed countries with profound public health challenges."

In the coming months, Caliber will be announcing new major strategic alliances and its priorities for product development.

About Caliber Biotherapeutics

Caliber Biotherapeutics is a fully integratedbiopharmaceutical companydedicated to creating greater and faster access toprotein therapeuticsandvaccinesfor cancer,infectious and orphan diseases.Thecompany leverages highly agile, modularproduction technology and plant-,cell-,and microbial-based systemscapableof accelerating delivery ofnovel treatments with increased efficacyandsafety

Headquartered in Bryan / College Station, Texas, CaliberBiotherapeutics hasassembleda world-class team of experts and established the world's largestplant-made pharmaceuticals facility that uniquely responds tochanging demands andscale requirements. For moreinformation, pleasevisitthecompany's website atwww.caliberbio.com

SOURCE Caliber Biotherapeutics



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES